https://ipharmag.com/article/tyrosine-brain-supplement-lifespan-men-study iPharmag en 2026-09-07T02:15:22+00:00 A Study Tied Higher Tyrosine Levels to Shorter Lifespan in Men — With Big Caveats https://ipharmag.com/article/medicines-discovery-catapult-flip-nascent-biotech iPharmag en 2026-09-07T02:15:22+00:00 UK Innovation Body Backs Two Biotechs Chasing Autoimmune and Aging Diseases https://ipharmag.com/article/latam-fingers-lifestyle-cognition-dementia-trial iPharmag en 2026-09-07T02:15:22+00:00 A Coached Lifestyle Program Boosted Cognition 55% More Than Health Advice Alone https://ipharmag.com/article/breast-cancer-dormant-cells-protective-shields iPharmag en 2026-09-07T02:15:22+00:00 Breast Cancer Cells Survive Treatment by Hiding Behind Cellular ‘Shields’ https://ipharmag.com/article/american-regent-epinephrine-injection-recall-particulate iPharmag en 2026-09-07T02:15:22+00:00 American Regent Recalls Epinephrine Injection Vials Over Cracks and Particles https://ipharmag.com/article/venetoclax-siv-reservoir-macaques-hiv-cure iPharmag en 2026-09-06T00:22:12+00:00 A Cancer Drug Shrank the Hidden HIV Reservoir in Monkeys — a Clue for a Cure https://ipharmag.com/article/ultragenyx-gtx102-angelman-syndrome-trial-failure iPharmag en 2026-09-06T00:22:12+00:00 Ultragenyx Stock Halves After Its Angelman Syndrome Drug Fails a Pivotal Trial https://ipharmag.com/article/typewriter-56m-non-viral-in-vivo-gene-therapy iPharmag en 2026-09-06T00:22:12+00:00 Typewriter Raises $56M to Ditch Viruses From Gene Therapy https://ipharmag.com/article/fda-neonatal-parenteral-nutrition-supply-newborns iPharmag en 2026-09-06T00:22:12+00:00 FDA Moves to Keep IV ‘Starter Nutrition’ Flowing to Fragile Newborns https://ipharmag.com/article/alzheimers-cortical-changes-before-amyloid-plaques iPharmag en 2026-09-06T00:22:12+00:00 Alzheimer’s May Mark the Brain Years Before Plaques Show Up